JGSDF Triples Deployment of Medirom's Remote Health Monitoring System
MRM sits 16% above its 52-week low of $0.9 on elevated volume (2.2× avg).
Summary
Medirom's subsidiary, MEDIROM MOTHER Labs, secured an additional order from the Japan Ground Self-Defense Force (JGSDF) 8th Division for its "REMONY®" remote health monitoring system. This expands the deployment scale to approximately three times the initial implementation. This follows the 6-K filing earlier today that disclosed the additional order. For a micro-cap company, significantly expanding a contract with a government client like the JGSDF is a material positive development, validating its technology and opening doors for future growth.
At the time of this announcement, MRM was trading at $1.04 on NASDAQ in the Technology sector, with a market capitalization of approximately $8.5M. The 52-week trading range was $0.90 to $4.45. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.